From pharmacokinetics to pharmacodynamics – Are we ready for 3D software?

Gambús, 2015, Pharmacokinetic–pharmacodynamic modelling in anaesthesia, Br J Clin Pharmacol, 79, 72, 10.1111/bcp.12286 Billard, 2015, Pharmacokinetic–pharmacodynamic relationship of anesthetic drugs: from modeling to clinical use, Faculty Rev, 4, F1000 Bocanegra, 2015 Tafur, 2010, Anestesia total intravenosa: de la farmacéutica a la farmacocinética, Rev Colomb Anestesiol, 38, 215, 10.1016/S0120-3347(10)82005-2 Hendrickx, 2008, Is synergy the rule? A review of anesthetic interactions producing hypnosis and immobility, Anesth Analg, 107, 494, 10.1213/ane.0b013e31817b859e GE Healthcare, 2017 Dräger SmartPilot® View, 2017 Cirillo, 2015, Navigator® and SmartPilot® view are helpful in guiding anesthesia and reducing anesthetic drug dosing, Minerva Anestesiol, 1 Mertens, 2003, Propofol reduces perioperative remifentanil requirements in a synergistic manner: response surface modeling of perioperative remifentanil–propofol interactions, Anesthesiology, 99, 347, 10.1097/00000542-200308000-00016 Minto, 2000, Response surface model for anesthetic drug interactions, Anesthesiology, 92, 1603, 10.1097/00000542-200006000-00017 Vuyk, 2001, Clinical interpretation of pharmacokinetic and pharmacodynamic propofol–opioid interactions, Acta Anaesthesiol Belg, 52, 445 Nieuwenhuijs, 2003, Response surface modeling of remifentanil–propofol interaction on cardiorespiratory control and bispectral index, Anesthesiology, 98, 312, 10.1097/00000542-200302000-00008 Bouillon, 2002, Non-steady state analysis of the pharmacokinetic interaction between propofol and remifentanil, Anesthesiology, 97, 1350, 10.1097/00000542-200212000-00005